Cell Growth & Differentiation, Vol 7, Issue 11 1507-1512, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells

A Basu, K Weixel and N Saijo
Department of Pharmacology, University of Pittsburgh, Pennsylvania 15261, USA. anb@prophet.pharm.pitt.edu

Protein kinase C (PKC) influences cellular sensitivity to cis-diamminedichloroplatinum(II) (cDDP). We have investigated whether the PKC signal transduction pathway is affected during the development of cellular resistance to cDDP. Activators of PKC, such as phorbol 12,13-dibutyrate (PDBu), enhanced the sensitivity of human small cell lung cancer H69 cells to cDDP by 2-fold but had no effect on the sensitivity of cDDP-resistant H69 cells (H69/CP) to cDDP. The maximum sensitization was achieved with 10 nM PDBu and blocked by down-regulation of PKC with higher concentrations of PDBu (1 microM) or bryostatin 1 (0.1 microM). PKC activity was decreased significantly in H69/CP cells compared to the drug-sensitive variant. A similar reduction in PKC activity was noted in ovarian carcinoma 2008 cells that were resistant to cDDP. A modest decrease in PKC activity was also observed in etoposide-resistant H69 (H69/VP-16) cells but not in Taxol-resistant H69 cells or bleomycin-resistant human head and neck carcinoma A-253 cells. H69 cells expressed conventional PKC alpha and-beta, novel PKC delta, atypical PKC zeta and-iota, and novel/atypical PKC mu. A decrease in cPKC alpha and-beta and an increase in nPKC delta were associated with the cDDP-resistant phenotype. The abundance of aPKC zeta or-iota was unaffected. H69/ VP-16 cells also displayed a reduction in cPKC beta and an increase in nPKC delta. Taxol-resistant H69 cells had no alteration in the expression of any of the PKC isozymes. Thus, a reduction in cPKCs and an increase in nPKC may be associated with cDDP resistance.

This article has been cited by other articles:

				S. Amos, M. Mut, C. G. diPierro, J. E. Carpenter, A. Xiao, Z. A. Kohutek, G. T. Redpath, Y. Zhao, J. Wang, M. E. Shaffrey, et al. Protein Kinase C-{alpha} Mediated Regulation of Low-Density Lipoprotein Receptor Related Protein and Urokinase Increases Astrocytoma Invasion Cancer Res., November 1, 2007; 67(21): 10241 - 10251. [Abstract] [Full Text] [PDF]

				S. Kumar Biswas, J. Huang, S. Persaud, and A. Basu Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells Mol. Cancer Ther., March 1, 2004; 3(3): 327 - 334. [Abstract] [Full Text]

				A. S. Clark, K. A. West, P. M. Blumberg, and P. A. Dennis Altered Protein Kinase C (PKC) Isoforms in Non-Small Cell Lung Cancer Cells: PKC{delta} Promotes Cellular Survival and Chemotherapeutic Resistance Cancer Res., February 15, 2003; 63(4): 780 - 786. [Abstract] [Full Text] [PDF]

				L. Ding, H. Wang, W. Lang, and L. Xiao Protein Kinase C-epsilon Promotes Survival of Lung Cancer Cells by Suppressing Apoptosis through Dysregulation of the Mitochondrial Caspase Pathway J. Biol. Chem., September 13, 2002; 277(38): 35305 - 35313. [Abstract] [Full Text] [PDF]

				C. L. Johnson, D. Lu, J. Huang, and A. Basu Regulation of p53 Stabilization by DNA Damage and Protein Kinase C Mol. Cancer Ther., August 1, 2002; 1(10): 861 - 867. [Abstract] [Full Text] [PDF]

				D. MECHTCHERIAKOVA, G. SCHABBAUER, M. LUCERNA, M. CLAUSS, R. DE MARTIN, B. R. BINDER, and E. HOFER Specificity, diversity, and convergence in VEGF and TNF-{alpha} signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells FASEB J, January 1, 2001; 15(1): 230 - 242. [Abstract] [Full Text] [PDF]

				R. van Gijn, X. Zuidema, A. Bult, and J. H. Beijnen Protein kinase C as a target for new anti-cancer agents Journal of Oncology Pharmacy Practice, December 1, 1999; 5(4): 166 - 178. [Abstract] [PDF]

				L. Paolucci and E. Rozengurt Protein Kinase D in Small Cell Lung Cancer Cells: Rapid Activation through Protein Kinase C Cancer Res., February 1, 1999; 59(3): 572 - 577. [Abstract] [Full Text] [PDF]

				A. Basu The Involvement of Novel Protein Kinase C Isozymes in Influencing Sensitivity of Breast Cancer MCF-7 Cells to Tumor Necrosis Factor-alpha Mol. Pharmacol., January 1, 1998; 53(1): 105 - 111. [Abstract] [Full Text]